ABSI
Absci Corporation
Latest News for ABSI
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on AbSci (ABSI) and RenovoRx (RNXT) with bullish sentim......
Guggenheim analyst reiterated a Buy rating on AbSci yesterday and set a price target of $10.00. The company’s shares closed yesterday at $3.01. The......
In a report released today, Gil Blum from Needham maintained a Buy rating on AbSci, with a price target of $7.00. Blum covers the Healthcare sector......
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Fractyl Health, Inc. (GUTS), AbSci (ABSI) and Alnylam Pharma (ALN......
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Amylyx Pharmaceuticals Inc (AMLX), AbSci (ABSI) and ......
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on AbSci (ABSI) and Cochlear (CHEOF) with bullish senti......
AbSci ( ($ABSI) ) has provided an update. On March 24, 2026, Absci reported fourth quarter and full-year 2025 results, highlighting clinical progre......
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Healthequity (HQY – Research Report) and AbSci (ABSI......
News data is sourced from MarketXLS API and updated regularly.
Showing 8 of 8 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ABSI | $2.92 | 0% | 3.78M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |